Teva Pharmaceutical Industries (TEVA) News Today $21.97 +0.29 (+1.32%) As of 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Teva's SWOT analysis: stock poised for growth as legal hurdles clearJanuary 17 at 7:02 PM | msn.comHennessy Advisors Inc. Has $16.01 Million Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Hennessy Advisors Inc. lifted its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 6.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 726,600 shares of the company's stock after pJanuary 17 at 8:25 AM | marketbeat.comPiper Sandler Forecasts Strong Price Appreciation for Teva Pharmaceutical Industries (NYSE:TEVA) StockPiper Sandler raised their price objective on shares of Teva Pharmaceutical Industries from $23.00 to $30.00 and gave the stock an "overweight" rating in a research note on Friday.January 17 at 7:34 AM | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by Assenagon Asset Management S.A.Assenagon Asset Management S.A. lowered its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 16.6% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,159,681 shares of the company's stock after selling 230,January 17 at 4:09 AM | marketbeat.comHennion & Walsh Asset Management Inc. Purchases 61,467 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Hennion & Walsh Asset Management Inc. boosted its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 19.8% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 371,583 shares ofJanuary 16 at 9:32 AM | marketbeat.comRedhawk Wealth Advisors Inc. Makes New Investment in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Redhawk Wealth Advisors Inc. bought a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 52,416 shares of the company's stock,January 16 at 6:43 AM | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Receives $20.88 Average Price Target from AnalystsTeva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eight ratings firms that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating and six have given a buy rJanuary 16 at 3:19 AM | marketbeat.comPFW Advisors LLC Acquires New Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)PFW Advisors LLC acquired a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 25,990 shares of the company'sJanuary 13, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (TEVA) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)January 13, 2025 | seekingalpha.comTeva Pharmaceutical’s Growth Potential and Strategic Market PositioningJanuary 13, 2025 | markets.businessinsider.comHow Teva Pharmaceuticals is thinking about Trump's return: CEOJanuary 13, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eight brokerages that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating andJanuary 13, 2025 | marketbeat.comTeva Announces Collaboration to Commercialize Formycon's Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in IsraelJanuary 13, 2025 | globenewswire.comFirst Hawaiian Bank Acquires Shares of 32,804 Teva Pharmaceutical Industries Limited (NYSE:TEVA)First Hawaiian Bank acquired a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 32,804 shares of the companJanuary 11, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd (TEVA) Partners with Samsung Bioepis for U.S. ...January 10, 2025 | gurufocus.comSamsung Bioepis, Teva Enter License, Development, Commercialization Agreement For EPYSQLIJanuary 10, 2025 | markets.businessinsider.comSamsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United StatesJanuary 10, 2025 | globenewswire.comCWA Asset Management Group LLC Makes New Investment in Teva Pharmaceutical Industries Limited (NYSE:TEVA)CWA Asset Management Group LLC purchased a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 151,537 shares of the compJanuary 7, 2025 | marketbeat.comTeva Pharmaceutical: Why Diversity in Clinical Trials Is So ImportantJanuary 6, 2025 | finanznachrichten.deCentral Pacific Bank Trust Division Invests $935,000 in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Central Pacific Bank Trust Division acquired a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 42,427 sharesJanuary 4, 2025 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Stock Price Passes Above 200 Day Moving Average - What's Next?Teva Pharmaceutical Industries (NYSE:TEVA) Share Price Crosses Above 200 Day Moving Average - Here's WhyJanuary 3, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market BloodbathDecember 28, 2024 | insidermonkey.comTeva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market BloodbathDecember 28, 2024 | msn.comDuvakitug And Teva's Growth: A Game Changer In PharmaDecember 27, 2024 | seekingalpha.comInsider Selling: Teva Pharmaceutical Industries Limited (NYSE:TEVA) Director Sells 286,000 Shares of StockDecember 27, 2024 | insidertrades.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Director Sells $6,294,860.00 in StockTeva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) Director Roberto Mignone sold 286,000 shares of the firm's stock in a transaction dated Friday, December 20th. The shares were sold at an average price of $22.01, for a total transaction of $6,294,860.00. Following the sale, the director now directly owns 695,000 shares in the company, valued at approximately $15,296,950. The trade was a 29.15 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.December 26, 2024 | marketbeat.comFranklin Resources Inc. Increases Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Franklin Resources Inc. boosted its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 141.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 155,091 shares of the companyDecember 26, 2024 | marketbeat.comTidal Investments LLC Sells 28,619 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Tidal Investments LLC lowered its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 67.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 13,856 shares of the company's stock after selling 28,619 sharesDecember 26, 2024 | marketbeat.comWhy Teva Pharmaceuticals Industries (TEVA) Skyrocketed?December 24, 2024 | msn.comBillionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2025December 24, 2024 | fool.comTeva put volume heavy and directionally bearishDecember 23, 2024 | markets.businessinsider.comTeva Pharmaceutical Industries Ltd (TEVA) to Present at J.P. Morgan Healthcare ConferenceDecember 23, 2024 | gurufocus.comTeva Pharmaceutical Industries Ltd (TEVA) to Present at J.P. Morgan Healthcare ConferenceDecember 23, 2024 | gurufocus.comInvestors Buy High Volume of Put Options on Teva Pharmaceutical Industries (NYSE:TEVA)Teva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) saw unusually large options trading on Monday. Traders acquired 37,691 put options on the company. This is an increase of 38% compared to the average daily volume of 27,275 put options.December 23, 2024 | marketbeat.comTeva to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 23, 2024 | globenewswire.comTeva Pharmaceutical Industries (NYSE:TEVA) Hits New 12-Month High - Time to Buy?Teva Pharmaceutical Industries (NYSE:TEVA) Sets New 1-Year High - Here's What HappenedDecember 23, 2024 | marketbeat.comStifel Financial Corp Has $1.20 Million Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Stifel Financial Corp raised its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 54.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 66,391 shares of the company'December 23, 2024 | marketbeat.comTeva Pharmaceutical Industries Ltd (TEVA) Announces Upcoming Financial Results Release and ...December 21, 2024 | gurufocus.comTeva Pharmaceutical Industries Limited (TEVA): A Bull Case TheoryDecember 21, 2024 | insidermonkey.comTeva loses US appeal to keep inhaler patents on FDA protected drug listDecember 21, 2024 | reuters.comTeva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025December 20, 2024 | financialpost.comTeva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025December 20, 2024 | globenewswire.comTeva Pharmaceutical (TEVA) Gets a Hold from J.P. MorganDecember 19, 2024 | markets.businessinsider.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Given Consensus Rating of "Moderate Buy" by BrokeragesTeva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) has received an average recommendation of "Moderate Buy" from the eight ratings firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and six have given aDecember 19, 2024 | marketbeat.comBarclays PLC Has $7.71 Million Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Barclays PLC lifted its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 31.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 427,595 shares of the company's stock after buying an additional 102,December 19, 2024 | marketbeat.comStockNews.com Downgrades Teva Pharmaceutical Industries (NYSE:TEVA) to BuyStockNews.com cut shares of Teva Pharmaceutical Industries from a "strong-buy" rating to a "buy" rating in a report on Wednesday.December 18, 2024 | marketbeat.comJim Cramer on Teva Pharmaceutical Industries (TEVA): A Game-Changer for Intractable Disease Treatments?December 18, 2024 | insidermonkey.comTeva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related DiseasesDecember 18, 2024 | benzinga.comBarclays Issues Positive Forecast for Teva Pharmaceutical Industries (NYSE:TEVA) Stock PriceBarclays upped their target price on Teva Pharmaceutical Industries from $25.00 to $28.00 and gave the stock an "overweight" rating in a research report on Wednesday.December 18, 2024 | marketbeat.comPositive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn'sDecember 17, 2024 | investopedia.com Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address TEVA Media Mentions By Week TEVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼0.640.72▲Average Medical News Sentiment TEVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼149▲TEVA Articles Average Week Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News TAK News ARGX News BNTX News BGNE News GMAB News VTRS News ITCI News SMMT News MRNA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TEVA Stock Alerts